Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | PE(40:8e)/PE(40:7p) | Lipid-depleted/compactin | 0.0 | BCD100322A02 | 91.6 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | Lipid-depleted/compactin | 0.5 | BCD100322A05 | 129 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | Lipid-depleted/compactin | 1.0 | BCD100322A09 | 118 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | Lipid-depleted/compactin | 2.0 | BCD100322A13 | 127 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | Lipid-depleted/compactin | 4.0 | BCD100322A17 | 124 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | Lipid-depleted/compactin | 8.0 | BCD100322A21 | 142 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | Lipid-depleted/compactin | 12.0 | BCD100322A25 | 149 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | Lipid-depleted/compactin | 24.0 | BCD100322A29 | 192 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | C | 0.0 | BCD100322A01 | 193 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | C | 0.5 | BCD100322A03 | 113 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | C | 1.0 | BCD100322A07 | 146 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | C | 2.0 | BCD100322A11 | 177 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | C | 4.0 | BCD100322A15 | 105 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | C | 8.0 | BCD100322A19 | 120 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | C | 12.0 | BCD100322A23 | 138 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | C | 24.0 | BCD100322A27 | 182 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A06 | 156 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A10 | 160 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A14 | 268 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A18 | 131 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A22 | 131 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A26 | 142 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A30 | 177 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | 25OH-Chol | 0.5 | BCD100322A04 | 115 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | 25OH-Chol | 1.0 | BCD100322A08 | 163 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | 25OH-Chol | 2.0 | BCD100322A12 | 170 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | 25OH-Chol | 4.0 | BCD100322A16 | 132 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | 25OH-Chol | 8.0 | BCD100322A20 | 117 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | 25OH-Chol | 12.0 | BCD100322A24 | 112 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | 25OH-Chol | 24.0 | BCD100322A28 | 190 | pmol/sample |